Toxicities of CD19 CAR‐T cell immunotherapy is a research paper published in American Journal of Hematology (2019). On theSindex it has a DataRank of 6.3. It has been cited 139 times, with 135 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.741
From this paper's citation signal
Citation Network Contribution
5.6
From 115 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 135 citers.
Nektar Therapeutics
Juno Therapeutics
MeSH Terms
Additional file 1 of Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
Additional file 1 of Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
Additional file 1 of Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk
Additional file 1 of Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk
Additional file 2 of Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk
Additional file 2 of Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk